NeuroSense Therapeutics Ltd — Balance Sheet (NASDAQ:NRSN)

Financials

Total assets 11.43 M7.71 M3.18 M4.58 M Total liabilities 2.42 M2.09 M5.05 M1.99 M Total equity 9.01 M5.62 M1.87 M2.58 M Total liabilities & shareholders' equities 11.43 M7.71 M3.18 M4.58 M Total debt ———— Net debt ————

新闻

Neurosense Therapeutics股价在获得PrimeC澳大利亚专利后上涨

Neurosense Therapeutics stock rises after securing Australian patent for PrimeC

NeuroSense股价上涨，阿尔茨海默病药物显示良好安全性

Neurosense stock rises as Alzheimer’s drug shows favorable safety profile

NRSN stock touches 52-week high at $1.65 amid robust gains

NRSN stock touches 52-week high at $1.52 amid growth optimism

Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights - NeuroSense Therapeutics (NASDAQ:NRSN)

This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday - NeuroSense Therapeutics (NASDAQ:NRSN), Primis Finl (NASDAQ:FRST)